GEHC
XNAS
Market cap36bUSD
Nov 20, Last price
80.64USD
1D
-1.53%
1Q
7.78%
IPO
33.31%
Name
GE Healthcare Technologies Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Related entities
Subsidiaries (5)
GE HEALTHCARE (AB)
GE HEALTHCARE GLOBAL PRIVATE LIMITED
GE HEALTHCARE TRANSNATIONAL HOLDINGS, LLC
GE HEALTHCARE VIETNAM COMPANY LIMITED
BK MEDICAL ApS
Key people
H. Lawrence Culp
Chairman of the Board · since 2023
Peter Arduini
President, Chief Executive Officer, Director · since 2023
James Saccaro
Chief Financial Officer, Vice President · since 2023
Jeannette Bankes
Chief Executive Officer - Patient Care Solutions · since 2025
Kevin O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics · since 2023
Philip Rackliffe
President and CEO - Advanced Visualization Solutions · since 2025
Roland Rott
President and CEO - Imaging · since 2024
Adam Holton
Chief People Officer · since 2024
Taha Kass - Hout
Chief Science and Technology Officer · since 2023
Frank Jimenez
General Counsel, Corporate Secretary · since 2023
Kenneth Stacherski
Chief Global Supply Chain and Service Officer · since 2022
Lead Independent Director · since 2023
Rodney Hochman
Independent Director · since 2023
Catherine Lesjak
Independent Director · since 2022
Anne Madden
Independent Director · since 2023
Tomislav Mihaljevic
Independent Director · since 2023
William Stromberg
Independent Director · since 2023
Phoebe Yang
Independent Director · since 2023
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
500 West Monroe Street
Chicago, IL 60661
US
Chicago, IL 60661
US
Previous name
GE Healthcare Holding LLC
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||